+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A study of the effect of the thyrotropin-releasing hormone metabolite, histidyl-proline diketopiperazine, on prolactin secretion in vivo



A study of the effect of the thyrotropin-releasing hormone metabolite, histidyl-proline diketopiperazine, on prolactin secretion in vivo



Endocrinology 109(5): 1375-1379



TRH, a PRL secretogogue, is metabolized to histidyl-proline diketopiperazine (HPD) in brain and plasma. HPD has been reported to inhibit PRL secretion in vitro. In the present study, intravascular pulse injections or infusions of HPD were carried out in the rat to determine whether HPD affected 1) TRH-induced PRL secretion, 2) the PRL proestrous surge, 3) the PRL surge in the ovariectomized, estrogen-primed rat and 4) pimozide-induced hyperprolactinemia. HPD had no effect on TRH-induced PRL secretion in estrogen-primed male rats when administered in molar ratios of 1:1.5 to 1:150 (TRH:HPD). The infusion of 1 microgram/min HPD for 360 min to rats before and during the proestrous PRL surge did not inhibit or augment PRL secretion, nor was there any influence of pulse injections of HPD on PRL secretion during the proestrous surge. HPD did not influence spontaneous PRL surges in the ovariectomized estrogen-primed rat. Finally, HPD, given with pimozide and again 2 days later, did not influence the PRL surge after pimozide administration or the elevated serum PRL concentrations noted 2 days after pimozide treatment. Despite the promising in vitro data demonstrating that the TRH metabolite, HPD, has PRL inhibitory factor activity, this study does not support the concept that HPD is a physiological PRL inhibitory factor.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 042125098

Download citation: RISBibTeXText

PMID: 7197618

DOI: 10.1210/endo-109-5-1375


Related references

Influence of thyrotropin-releasing hormone and its major metabolite histidyl-proline diketopiperazine on enzyme secretion from isolated rat exocrine pancreatic acinar cells. European Journal of Clinical Investigation 24(Suppl. 2): A16, 1994

Detection in human serum by radioimmunoassay of histidyl-proline diketopiperazine, a metabolite of thyrotropin-releasing hormone. Journal of Clinical Endocrinology and Metabolism 56(2): 312-319, 1983

Antagonism of ethanol-induced decrease in rat brain cGMP concentration by histidyl-proline diketopiperazine, a thyrotropin releasing hormone metabolite. Biochemical and Biophysical Research Communications 86(4): 1146-1153, 1979

A fast protein liquid chromatography (FPLC) method for study of thyrotropin-releasing hormone (TRH) and its metabolite histidyl-proline diketopiperazine (CHP) in human blood: degradation in liver and pancreatic diseases. Neuropeptides 25(6): 357-361, 1993

Thyrotropin-releasing hormone and histidyl-proline diketopiperazine: stimulation of secretion from hypothalamic fragments in vitro by depolarizing agents. Endocrinology 120(3): 915-918, 1987

Influence of thyrotropin-releasing hormone and histidyl-proline-diketopiperazine on enzyme secretion from isolated rat exocrine pancreatic acinar cells. Leber Magen Darm 24(4): 156-160, 163, 1994

Inhibiting effect of the thyrotropin releasing hormone metabolite histidyl proline di keto piperazine on ketamine induced prolactin release in rhesus monkeys. Acta Endocrinologica Suppl. 94(234): 3-4, 1980

Effect of thyrotropin releasing hormone and histidyl-proline diketopiperazine on enzyme section of isolated pancreatic acinar cells of the rat. Leber Magen Darm 24(4): 156-60 163, 1994

Effects of histidyl proline di keto piperazine a metabolite of thyrotropin releasing hormone on prolactin release by the rat pituitary gland in vitro. European Journal of Pharmacology 71(2-3): 337-342, 1981

Histidyl-proline diketopiperazine. Novel formation that does not originate from thyrotropin-releasing hormone. Journal of Biological Chemistry 268(28): 20863-5, 1993

The antinociceptive effects of histidyl-proline diketopiperazine and thyrotropin-releasing hormone in the mouse. European Journal of Pharmacology 112(3): 287-294, 1985

The TRH-metabolite histidyl-proline-diketopiperazine (DKP) inhibits prolactin secretion in male rhesus monkeys. European Journal of Endocrinology 98(2): 189-194, 1981

Inhibition of in vitro prolactin secretion by histidyl proline di keto piperazine a degradation product of thyrotropin releasing hormone. European Journal Of Pharmacology: 97-98, 1979

Regional dissociation of histidyl--proline diketopiperazine (cyclo-(His--Pro)) and thyrotropin-releasing hormone (TRH) in the rat brain. Brain Research 231(2): 451-453, 1982

The effects of thyrotropin releasing hormone and histidyl-proline diketopiperazine on delta-9-tetrahydrocannabinol-induced hypothermia. Life Sciences 26(11): 845-850, 1980